NAD+ Forums

This human study shows that long-term treatment with dulaglutide might reduce cognitive impairment in people with type 2 diabetes.
This is the first treatment proven efficacy in attenuating cognitive decline in people with diabetes.
https://www.sciencedirect.com/science/a ... 2220301733

AlbertY wrote: ↑Mon Jun 29, 2020 9:15 pm This human study shows that long-term treatment with dulaglutide might reduce cognitive impairment in people with type 2 diabetes.
This is the first treatment proven efficacy in attenuating cognitive decline in people with diabetes.
https://www.sciencedirect.com/science/a ... 2220301733

This is interesting for sure! Would it be safe for someone without Type 2 diabetes to take this?

Is it too soon to tell?

NewLifeScience wrote: ↑Tue Jul 07, 2020 8:48 am
This is interesting for sure! Would it be safe for someone without Type 2 diabetes to take this?

Is it too soon to tell?

Well, it hard to say, but note that T2D is a great risk factor for CVD and dementia. So it is possible that this drug only works in diabetic patients by reducing this risk through a specific pathway, but not in non-diabetic patients.

For T2D patients, definitely consider taking it under doctor's supervision.

:Got it.

Thanks Albert.

Sad to say I know too many people with T2D.